Renalytix plc Research and Development in Process
Renalytix plc (RENXF) reported Research and Development in Process of $35.29 million for the 12-month period ending 2019-06-30, per its 20-F/A filed 2022-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-08-01
| Period end | Research and Development in Process 12 month |
|---|---|
| 2019-06-30 | $35.29M 20-F/A · filed 2022-08-01 |